Company news
ImmuPharma plc news in 2020
ImmuPharma plc's news releases, calls and decks from 2020, newest first.
IMM to present at biotech showcase digital 2021
December 2, 2020
Total Share Capital Notification
November 30, 2020
Grant of Share Options & PDMR dealing
November 26, 2020
Conversion of Convertible Security
November 24, 2020
Update: FDA confirms 4 Dec for Type 'A' meeting
November 20, 2020
Total Share Capital Notification - Replacement
November 18, 2020
Update on submission to the FDA
November 10, 2020
Share Subscription into Incanthera plc
September 29, 2020
Repayment of Convertible Security
September 22, 2020
Director/PDMR Shareholding / TR -1
September 8, 2020
Placing - update; related party transaction)
September 7, 2020
Placing to raise £6.5 million
September 2, 2020
FDA submission for Special Protocol Assessment
July 27, 2020
2020 Agm - all resolutions passed
June 18, 2020
Strat. invts from 2 specialist US h'care investors
June 11, 2020
Change of Registered Office Address
June 5, 2020
Notification of Change of AGM Venue
June 2, 2020
Efforts in fight vs Covid-19 with Lupuzor; Ureka
May 14, 2020
Audited Report & Accounts published on website
April 30, 2020
IMM live on Investor Meet Company platform 7 April
April 6, 2020
£1.5m Subscrip'n to fund R&D pipeline- replacement
March 30, 2020
Incanthera plc - Admission to trading on NEX
February 28, 2020
Incanthera announces Rule 23 Notice re NEX listing
February 17, 2020
Update on the Avion Agreement
February 6, 2020
Decks in 2020
- Investor Presentation (April 2020)
Investor deck · 15 slides · April 2020